Home

MATTHEW SIROVICH

CIK 1431208 · last filed 2020-11-27

MATTHEW SIROVICH is a corporate insider who has filed 29 SEC Form 4 insider transactions across 6 companies since 2008. The most recent filing shows the insider sold $170.9K of PAVMZ on Nov 27, 2020. Across all open-market trades the lifetime net is −$44.1M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $534.5M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$534.48M

Companies

6

Total Filings

29

Lifetime Open-Market Net

-$44.06M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PAVmed Inc. (PAVMZ) Delisted 10%+ Owner 2,966,041 $0.00 $2.7K -$755.6K 5 2020-11-27
ITRI 10%+ Owner 4,878,384 $83.93 $409.44M $45.05M 11 2019-05-23
Acorda Therapeutics, Inc. (ACOR) Delisted 10%+ Owner 42,826 $0.66 $28.3K -$89.77M 10 2019-01-11
Barzel Industries Inc. (TONSW) Delisted 10%+ Owner 2,573,409 — — $5.5K 1 2008-10-03
CENT 10%+ Owner 2,909,080 $42.98 $125.03M $437.4K 1 2008-04-23
SOURCE INTERLINK COMPANIES INC (SORC) Delisted 10%+ Owner 5,421,076 — — $963.7K 1 2008-04-02

Recent Filings

29 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2020-11-27 PAVmed Inc. (PAVMZ) Delisted Sell (S) −86,239 -$170.9K EDGAR
2020-11-20 PAVmed Inc. (PAVMZ) Delisted Sell (S) −100,000 -$181.6K EDGAR
2020-06-01 PAVmed Inc. (PAVMZ) Delisted Sell (S) −200,921 -$403.1K EDGAR
2020-02-03 PAVmed Inc. (PAVMZ) Delisted Exer (X) +1,199,383 $12.0K EDGAR
2019-05-23 ITRI — — $0 EDGAR
2019-03-13 ITRI Mixed −837,400 -$12.34M EDGAR
2019-01-28 PAVmed Inc. (PAVMZ) Delisted Other (J) +332,400 $0 EDGAR
2019-01-11 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −649,964 -$11.17M EDGAR
2018-12-26 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −162,024 -$2.14M EDGAR
2018-12-13 Acorda Therapeutics, Inc. (ACOR) Delisted Sell (S) −1,200,000 -$19.56M EDGAR
Showing 1–10 of 29
Page 1 of 3
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.